Elekta Signs Agreement With France's Centre de radiothérapie St Louis to Supply Monaco Treatment Planning Systems
TOULON, France, March. 6, 2018 /PRNewswire/ -- Officials at Centre de radiothérapie Saint Louis (Toulon, France) recently chose Elekta's Monaco® high precision radiotherapy treatment planning system as the replacement system for its Pinnacle systems. The center currently has several Elekta linear accelerators and MOSAIQ® oncology information system.
"We made a promising choice. Elekta has shown us step-by-step how to meet our future expectations. The relationship we have established promises to have a bright future," says Patrice Budillon, referent physicist at Centre de radiothérapie."
"The latest advances in computing speed have placed Monaco among the most competitive treatment planning systems. We are deeply convinced that with the ingenuity of Monaco, we will be able to exploit our Agility multileaf collimator to its maximum performance." adds Gunther Rucka, referent physicist at Centre de radiothérapie. Utilizing biological optimization and class solution templates, Monaco helps clinicians utilize voxel-based control for fast and efficient planning. With Smart Sequencing and Segment Shape Optimization (SSO) to support High Definition Dynamic Radiosurgery (HDRS), Monaco creates high-quality plans that maximize treatment efficiency and the capability of Elekta linear accelerators.
"Monaco represents a comprehensive system to support all major types of treatment modalities and delivers confidence with the Monte Carlo algorithm," says Ranjit Pradhan, Senior Vice President Oncology Informatics Portfolio. "And beyond the features and benefits of Monaco, Elekta is proud to be a total solutions provider for Centre de radiothérapie St Louis and support their excellence in patient care."
For further information, please contact:
Global EVP Corporate Communications and Investor Relations
Time zone: CET: Central European Time
Director, Global Media Relations
Time zone: ET: Eastern Time
Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com
This information was brought to you by Cision http://news.cision.com
The following files are available for download:
Upcoming Life Sciences Events
- June 2018
- Boston: World Preclinical Congress
- Basel: Biotech Outsourcing Strategies 2018
- London: BREXIT: What does it mean for the Life Sciences